Brendan P. Eckelman

Entity
Individual
Business address
C/O Inhibrx, Inc., 11025 N. Torrey Pines Road, Suite 200, 92037 La Jolla, CA
Signature Ownership
/s/ Kelly D. Deck, Chief Financial Officer of Inhibrx Biosciences, Inc., as attorney-in-fact
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Brendan P. Eckelman has filed 29 SEC EDGAR filings since 8/18/2020

Latest Filings